Farxiga and Photodermatosis - a phase IV clinical study of FDA data

Summary:

Photodermatosis is reported only by a few people who take Farxiga.

The phase IV clinical study analyzes which people take Farxiga and have Photodermatosis. It is created by eHealthMe based on reports of 14,198 people who have side effects while taking Farxiga from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 18, 2023

14,198 people reported to have side effects when taking Farxiga.
Among them, 2 people (0.01%) have Photodermatosis.

What is Farxiga?

Farxiga has active ingredients of dapagliflozin. It is often used in diabetes. eHealthMe is studying from 14,510 Farxiga users for its effectiveness, alternative drugs and more.

What is Photodermatosis?

Photodermatosis (skin disease that is caused by exposure to sunlight) is found to be associated with 333 drugs and 166 conditions by eHealthMe.

Number of Farxiga and Photodermatosis reports submitted per year:

Gender of people who have Photodermatosis when taking Farxiga *:

female: 100 %
male: 0.0 %

Age of people who have Photodermatosis when taking Farxiga *:

Common side effects people have besides Photodermatosis *:

Weight Decreased: 2 people, 100.00%
Intertrigo (inflammation (rash) of the body folds (adjacent areas of skin)): 2 people, 100.00%
Fungal Infection: 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Farxiga and have Photodermatosis?

Check whether Photodermatosis is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Photodermatosis and when was it recovered:

Photodermatosis in Farxiga

Expand to all the drugs that have ingredients of dapagliflozin:

Photodermatosis and drugs with ingredients of dapagliflozin

Alternative drugs to, pros and cons of Farxiga:

Farxiga (14,510 reports)

Common Farxiga side effects:

Browse all side effects of Farxiga:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Photodermatosis treatments and more:

Photodermatosis (660 reports)

COVID vaccines that are related to Photodermatosis:

Common drugs associated with Photodermatosis:

Prednisone: 152 reports
Voriconazole: 140 reports
Tacrolimus: 115 reports
Pantoprazole: 113 reports
Mycophenolate mofetil: 101 reports

All the drugs that are associated with Photodermatosis:

Photodermatosis (334 drugs)

All the conditions that are associated with Photodermatosis:

Photodermatosis (166 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on dapagliflozin (the active ingredients of Farxiga) and Farxiga (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.